Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience.
OBJECTIVE
Equivalent cross-relaxation rate (ECR) imaging is an MRI technique used to evaluate quantitatively a change in the protein-water interaction. We aimed to evaluate retrospectively the usefulness of ECR imaging for the histologic classification of malignant lymphoma (ML).


METHODS
Institutional Review Board approval was obtained and all patients provided informed consent. The study subjects included 15 patients with untreated ML who were histologically diagnosed with follicular lymphoma (FL; n = 8) or diffuse large B-cell lymphoma (DLBCL; n = 7). All patients underwent ECR imaging and the offset frequency was set at 7 ppm.


RESULTS
The median ECR values were 71% (range; 60.7 to 75.5) in FL and 54% (50.8 to 59.4) in DLBCL (p = 0.001). The median cellular density was 1.5 +/- 0.17 x 10(6) / mm(2) in FL and 1.0 +/- 0.70 x 10(6) / mm(2) in DLBCL (p = 0.001). The correlation coefficient between the ECR values and cellular density in ML was 0.88 (p = 0.001). In FL and DLBCL, assuming ECR value cut-off points of 60%, both sensitivity and specificity were 100%.


CONCLUSIONS
A strong correlation between ECR and cellular density in ML is demonstrated and the ECR may be a useful technique to differentiate between FL and DLBCL.
Nishiofuku
Hideyuki
H
Department of Radiology, Nara Medical University, Kashihara, Nara, Japan. nishiofukuhideyuki@yahoo.co.jp
Matsushima
Shigeru
S
Inaba
Yoshitaka
Y
Yamaura
Hidekazu
H
Sato
Yozo
Y
Morishima
Yasuo
Y
Kichikawa
Kimihiko
K
D000328:Adult; D000368:Aged; D002452:Cell Count; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D005260:Female; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods; D008224:Lymphoma, Follicular / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015588:Observer Variation; D012189:Retrospective Studies
Croat Med J. 2002 Oct;43(5):527-34
12402390
AJR Am J Roentgenol. 2007 Jun;188(6):1622-35
17515386
Magn Reson Imaging. 2003 Nov;21(9):1045-7
14684210
NMR Biomed. 2001 Oct;14(6):367-75
11599035
Magn Reson Med. 2005 Nov;54(5):1300-4
16217778
Cancer. 2005 Sep 1;104(5):1066-74
16047335
Phys Med Biol. 1999 May;44(5):1147-54
10368008
Magn Reson Imaging. 2002 Apr;20(3):285-93
12117611
Magn Reson Imaging. 2000 May;18(4):379-85
10788714
J Magn Reson Imaging. 2004 Jul;20(1):56-65
15221809
Magn Reson Imaging. 1995;13(6):837-46
8544655
J Clin Oncol. 2005 Jul 20;23(21):4643-51
15837966
J Pept Res. 1997 Dec;50(6):465-74
9440048
J Magn Reson Imaging. 2008 Jun;27(6):1278-83
18504747
Cancer. 2006 Jul 1;107(1):175-83
16721817
AJR Am J Roentgenol. 2005 Sep;185(3):711-6
16120924
AJNR Am J Neuroradiol. 1996 May;17(5):805-19
8733952
J Clin Oncol. 2005 Jul 20;23(21):4577-80
15837974